NETRF-funded research may help predict pancreatic neuroendocrine tumor (pNET) recurrence
(Neuroendocrine Tumor Research Foundation) NETRF-funded researchers identified a cancer cell type that is associated with non-functional pancreatic neuroendocrine tumor (pNET) recurrence. Alpha-like pNET cell expression of the protein ARX can guide prognosis.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news